The Effect of Multi-Task Learning on the Prediction of Neoantigen-MHC Class II Binding

Summary

Predicting cancer neoepitope binding to major histocompatibility complex (MHC) class II is crucial for therapeutic cancer vaccines. A novel deep learning model improves prediction accuracy, outperforming existing methods for neoantigen identification.